CommercialPrior AuthHigh impact
Cigna Specialty Care Options programs drug list expansion
Cigna·Oncology, Hematology, Rheumatology +3 more·Prior Authorization
We identified it
Jun 18, 2026
Summary
Cigna expanded their Specialty Care Options (SCO) and SCO+ programs to include additional specialty injectable medications that require site-of-care review and prior authorization. The programs aim to redirect patients from higher-intensity settings like outpatient hospitals to less intensive sites when clinically appropriate.
Action Required
Immediately: Review the expanded SCO and SCO+ drug lists on CignaforHCP.com under Resources > Reimbursement and Payment Policies > Precertification Policies. Update prior authorization workflows to include the newly added specialty injectables (20+ new drugs added between April 2025 and February 2026). Ensure staff obtain prior authorization for these medications before administration. Monitor the drug list frequently as it changes with new FDA approvals.